講師
- 籌備委員會成員
- 國際委員會
- 公司展望說明會
- Entrepreneur Pitch
- Session 1&2 – Global Biotech Development
- Session 3 – International Collaboration Strategy
- Session 4 – Exit Strategies for Early Stage New Drug Companies
- Session 5 – New Modalities to Cure
- Session 6 - BIO Asia–Taiwan 2022 Opening & Award Ceremony
- Session 7 - Future Pandemic Preparedness
- Session 8 – Healthcare Innovation Strategy
- Session 9 – Winning the Global Competition with Taiwanese DNA
- Session 10 – AI & Digital Health
- Session 11 – Novel Platforms for Biopharma Discovery
- Session 12 – Biologics Product Development and Manufacturing
- Session 13 – Advances in Cell & Gene Therapy
- Session 14 – CDMO Business for Small Molecules
- Special Forum – Emerging Opportunities when ICT meets BIO
- Session 16- AFOB Net Zero Emission Bioeconomy
- Session 17-Life Science Ventures in Australia
- Session 18-Life Science Ventures in India
- Session 19-Life Science Ventures in Japan
- Session 20-Life Science Ventures in Singapore
- Session 21-Life Science Ventures in UK
- Session 22–Life Science Ventures in Lithuania
- Satellite Conference
昱星生物科技股份有限公司
Company Info
Name /LumiSTAR Biotechnology, Inc.
Address /Rm. C524, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei City 115, Taiwan
Website /www.lumistar.com.tw
Presenter
Name /Chih-Chuan Su
Title /Business Development Manager
Email /chih-chuan.su@lumistar.com.tw
Telephone /+886-2-2783-5860
Fax /
Mobile /+886-935-877-816
Company Type
Biotechnology
About the Company
LumiSTAR Biotechnology is an expert on bioimaging and iPSC technology. Various platforms are developed by exploiting or packaging these two technologies together to make cellular response visualizable in real time using our designed protein-based indicators with different dynamic ranges for long-term observation and measurements, as they are non-toxic to the cells.
Available platforms, service and applications:
- iPSC-derived cells functional testing for cell therapy.
- iPSC disease models for drug screening.
- Pseudovirus screening platform.
- Personalized/Precision medicine
LumiSTAR’s platform has helped our clients successfully license out their drug pipeline.
Brief Description of main products or services
High Throughput Bioimaging Screening Platforms: Integration of a variety of technologies including iPSC, viral delivery system, pseudovirus, CRISPR, and live-cell imaging for real time recording cellular responses against testing drugs.
Applications:
For Drug Development:
For Cell Therapy:
- iPSC High Content/Throughput Screening Platform:
- Models for cardiac and neurodegenerative diseases are available.
- Drug efficacy study
- Toxicity can be evaluated at early stage.
- Support phenotypic screening
- iPSC cell reprogramming and differentiation development
- unctional testing platform for iPSC derived cells
- Pseudovirus High Throughput Imaging Screening Platform
- Pseudovirus construction for various strains
- Neutralizing antibody screening, vaccine validation and drug Screening
- Customized service is available
- Personalized/Precision Medicine